A citation-based method for searching scientific literature

Lesley-Ann Sutton, Viktor Ljungström, Anna Enjuanes, Diego Cortese, Aron Skaftason, Eugen Tausch, Katerina Stano Kozubik, Ferran Nadeu, Marine Armand, Jikta Malcikova, Tatjana Pandzic, Jade Forster, Zadie Davis, David Oscier, Davide Rossi, Paolo Ghia, Jonathan C Strefford, Sarka Pospisilova, Stephan Stilgenbauer, Frederic Davi, Elias Campo, Kostas Stamatopoulos, Richard Rosenquist, On Behalf Of The European Research Initiative On Cll Eric. Haematologica 2021
Times Cited: 3







List of co-cited articles
137 articles co-cited >1



Times Cited
  Times     Co-cited
Similarity


Integrated mutational and cytogenetic analysis identifies new prognostic subgroups in chronic lymphocytic leukemia.
Davide Rossi, Silvia Rasi, Valeria Spina, Alessio Bruscaggin, Sara Monti, Carmela Ciardullo, Clara Deambrogi, Hossein Khiabanian, Roberto Serra, Francesco Bertoni,[...]. Blood 2013
316
100

The evolutionary landscape of chronic lymphocytic leukemia treated with ibrutinib targeted therapy.
Dan A Landau, Clare Sun, Daniel Rosebrock, Sarah E M Herman, Joshua Fein, Mariela Sivina, Chingiz Underbayev, Delong Liu, Julia Hoellenriegel, Sarangan Ravichandran,[...]. Nat Commun 2017
77
100

Ibrutinib Regimens versus Chemoimmunotherapy in Older Patients with Untreated CLL.
Jennifer A Woyach, Amy S Ruppert, Nyla A Heerema, Weiqiang Zhao, Allison M Booth, Wei Ding, Nancy L Bartlett, Danielle M Brander, Paul M Barr, Kerry A Rogers,[...]. N Engl J Med 2018
308
100

Prognostic and predictive impact of genetic markers in patients with CLL treated with obinutuzumab and venetoclax.
Eugen Tausch, Christof Schneider, Sandra Robrecht, Can Zhang, Anna Dolnik, Johannes Bloehdorn, Jasmin Bahlo, Othman Al-Sawaf, Matthias Ritgen, Anna-Maria Fink,[...]. Blood 2020
23
100

Chronic lymphocytic leukaemia.
Thomas J Kipps, Freda K Stevenson, Catherine J Wu, Carlo M Croce, Graham Packham, William G Wierda, Susan O'Brien, John Gribben, Kanti Rai. Nat Rev Dis Primers 2017
170
100

Mutations driving CLL and their evolution in progression and relapse.
Dan A Landau, Eugen Tausch, Amaro N Taylor-Weiner, Chip Stewart, Johannes G Reiter, Jasmin Bahlo, Sandra Kluth, Ivana Bozic, Mike Lawrence, Sebastian Böttcher,[...]. Nature 2015
532
100

Clinical impact of small TP53 mutated subclones in chronic lymphocytic leukemia.
Davide Rossi, Hossein Khiabanian, Valeria Spina, Carmela Ciardullo, Alessio Bruscaggin, Rosella Famà, Silvia Rasi, Sara Monti, Clara Deambrogi, Lorenzo De Paoli,[...]. Blood 2014
213
100

Acquisition of the Recurrent Gly101Val Mutation in BCL2 Confers Resistance to Venetoclax in Patients with Progressive Chronic Lymphocytic Leukemia.
Piers Blombery, Mary Ann Anderson, Jia-Nan Gong, Rachel Thijssen, Richard W Birkinshaw, Ella R Thompson, Charis E Teh, Tamia Nguyen, Zhen Xu, Christoffer Flensburg,[...]. Cancer Discov 2019
139
100

Clinical impact of the subclonal architecture and mutational complexity in chronic lymphocytic leukemia.
F Nadeu, G Clot, J Delgado, D Martín-García, T Baumann, I Salaverria, S Beà, M Pinyol, P Jares, A Navarro,[...]. Leukemia 2018
51
100

Multiple productive IGH rearrangements denote oligoclonality even in immunophenotypically monoclonal CLL.
K Brazdilova, K Plevova, H Skuhrova Francova, H Kockova, M Borsky, V Bikos, J Malcikova, A Oltova, J Kotaskova, B Tichy,[...]. Leukemia 2018
12
66

Idelalisib and rituximab in relapsed chronic lymphocytic leukemia.
Richard R Furman, Jeff P Sharman, Steven E Coutre, Bruce D Cheson, John M Pagel, Peter Hillmen, Jacqueline C Barrientos, Andrew D Zelenetz, Thomas J Kipps, Ian Flinn,[...]. N Engl J Med 2014
66

Chronic lymphocytic leukemia: A prognostic model comprising only two biomarkers (IGHV mutational status and FISH cytogenetics) separates patients with different outcome and simplifies the CLL-IPI.
Julio Delgado, Michael Doubek, Tycho Baumann, Jana Kotaskova, Stefano Molica, Pablo Mozas, Alfredo Rivas-Delgado, Fortunato Morabito, Sarka Pospisilova, Emili Montserrat. Am J Hematol 2017
45
66

The t(14;19)(q32;q13)-positive small B-cell leukaemia: a clinicopathologic and cytogenetic study of seven cases.
Yang O Huh, Lynne V Abruzzo, George Z Rassidakis, Nilima Parry-Jones, Ellen Schlette, Vasantha Brito-Bapabulle, Estella Matutes, Andrew Wotherspoon, Michael J Keating, L Jeffrey Medeiros,[...]. Br J Haematol 2007
39
66

Chronic lymphocytic leukemia and regulatory B cells share IL-10 competence and immunosuppressive function.
D J DiLillo, J B Weinberg, A Yoshizaki, M Horikawa, J M Bryant, Y Iwata, T Matsushita, K M Matta, Y Chen, G M Venturi,[...]. Leukemia 2013
111
66

Ibrutinib plus obinutuzumab versus chlorambucil plus obinutuzumab in first-line treatment of chronic lymphocytic leukaemia (iLLUMINATE): a multicentre, randomised, open-label, phase 3 trial.
Carol Moreno, Richard Greil, Fatih Demirkan, Alessandra Tedeschi, Bertrand Anz, Loree Larratt, Martin Simkovic, Olga Samoilova, Jan Novak, Dina Ben-Yehuda,[...]. Lancet Oncol 2019
213
66

Randomized trial of ibrutinib vs ibrutinib plus rituximab in patients with chronic lymphocytic leukemia.
Jan A Burger, Mariela Sivina, Nitin Jain, Ekaterina Kim, Tapan Kadia, Zeev Estrov, Graciela M Nogueras-Gonzalez, Xuelin Huang, Jeffrey Jorgensen, Jianling Li,[...]. Blood 2019
80
66

Acalabrutinib monotherapy in patients with chronic lymphocytic leukemia who are intolerant to ibrutinib.
Farrukh T Awan, Anna Schuh, Jennifer R Brown, Richard R Furman, John M Pagel, Peter Hillmen, Deborah M Stephens, Jennifer Woyach, Elena Bibikova, Prista Charuworn,[...]. Blood Adv 2019
68
66

T cells from CLL patients exhibit features of T-cell exhaustion but retain capacity for cytokine production.
John C Riches, Jeffrey K Davies, Fabienne McClanahan, Rewas Fatah, Sameena Iqbal, Samir Agrawal, Alan G Ramsay, John G Gribben. Blood 2013
281
66

Highly similar genomic landscapes in monoclonal B-cell lymphocytosis and ultra-stable chronic lymphocytic leukemia with low frequency of driver mutations.
Andreas Agathangelidis, Viktor Ljungström, Lydia Scarfò, Claudia Fazi, Maria Gounari, Tatjana Pandzic, Lesley-Ann Sutton, Kostas Stamatopoulos, Giovanni Tonon, Richard Rosenquist,[...]. Haematologica 2018
21
66

Chromosomal translocations and karyotype complexity in chronic lymphocytic leukemia: a systematic reappraisal of classic cytogenetic data.
Panagiotis Baliakas, Michalis Iskas, Anne Gardiner, Zadie Davis, Karla Plevova, Florence Nguyen-Khac, Jitka Malcikova, Achilles Anagnostopoulos, Sharron Glide, Sarah Mould,[...]. Am J Hematol 2014
80
66

International prognostic score for asymptomatic early-stage chronic lymphocytic leukemia.
Adalgisa Condoluci, Lodovico Terzi di Bergamo, Petra Langerbeins, Manuela A Hoechstetter, Carmen D Herling, Lorenzo De Paoli, Julio Delgado, Kari G Rabe, Massimo Gentile, Michael Doubek,[...]. Blood 2020
24
66


Ibrutinib for patients with relapsed or refractory chronic lymphocytic leukaemia with 17p deletion (RESONATE-17): a phase 2, open-label, multicentre study.
Susan O'Brien, Jeffrey A Jones, Steven E Coutre, Anthony R Mato, Peter Hillmen, Constantine Tam, Anders Österborg, Tanya Siddiqi, Michael J Thirman, Richard R Furman,[...]. Lancet Oncol 2016
189
66

Monoclonal B-cell lymphocytosis and chronic lymphocytic leukemia.
Andy C Rawstron, Fiona L Bennett, Sheila J M O'Connor, Marwan Kwok, James A L Fenton, Marieth Plummer, Ruth de Tute, Roger G Owen, Stephen J Richards, Andrew S Jack,[...]. N Engl J Med 2008
366
66

Venetoclax for chronic lymphocytic leukaemia progressing after ibrutinib: an interim analysis of a multicentre, open-label, phase 2 trial.
Jeffrey A Jones, Anthony R Mato, William G Wierda, Matthew S Davids, Michael Choi, Bruce D Cheson, Richard R Furman, Nicole Lamanna, Paul M Barr, Lang Zhou,[...]. Lancet Oncol 2018
169
66

Richter transformation in chronic lymphocytic leukemia (CLL)-a pooled analysis of German CLL Study Group (GCLLSG) front line treatment trials.
O Al-Sawaf, S Robrecht, J Bahlo, A M Fink, P Cramer, J V Tresckow, E Lange, M Kiehl, M Dreyling, M Ritgen,[...]. Leukemia 2021
10
66

Clinical Practice Recommendations for Use of Allogeneic Hematopoietic Cell Transplantation in Chronic Lymphocytic Leukemia on Behalf of the Guidelines Committee of the American Society for Blood and Marrow Transplantation.
Mohamed A Kharfan-Dabaja, Ambuj Kumar, Mehdi Hamadani, Stephan Stilgenbauer, Paolo Ghia, Claudio Anasetti, Peter Dreger, Emili Montserrat, Miguel-Angel Perales, Edwin P Alyea,[...]. Biol Blood Marrow Transplant 2016
46
66

Etiology of Ibrutinib Therapy Discontinuation and Outcomes in Patients With Chronic Lymphocytic Leukemia.
Kami J Maddocks, Amy S Ruppert, Gerard Lozanski, Nyla A Heerema, Weiqiang Zhao, Lynne Abruzzo, Arletta Lozanski, Melanie Davis, Amber Gordon, Lisa L Smith,[...]. JAMA Oncol 2015
360
66

Biological and clinical implications of BIRC3 mutations in chronic lymphocytic leukemia.
Fary Diop, Riccardo Moia, Chiara Favini, Elisa Spaccarotella, Lorenzo De Paoli, Alessio Bruscaggin, Valeria Spina, Lodovico Terzi-di-Bergamo, Francesca Arruga, Chiara Tarantelli,[...]. Haematologica 2020
27
66

Linking aberrant chromatin features in chronic lymphocytic leukemia to transcription factor networks.
Jan-Philipp Mallm, Murat Iskar, Naveed Ishaque, Lara C Klett, Sabrina J Kugler, Jose M Muino, Vladimir B Teif, Alexandra M Poos, Sebastian Großmann, Fabian Erdel,[...]. Mol Syst Biol 2019
10
66

Specific NOTCH1 antibody targets DLL4-induced proliferation, migration, and angiogenesis in NOTCH1-mutated CLL cells.
Mónica López-Guerra, Sílvia Xargay-Torrent, Patricia Fuentes, Jocabed Roldán, Blanca González-Farré, Laia Rosich, Elisabeth Silkenstedt, María J García-León, Eriong Lee-Vergés, Neus Giménez,[...]. Oncogene 2020
9
66

The Light Chain IgLV3-21 Defines a New Poor Prognostic Subgroup in Chronic Lymphocytic Leukemia: Results of a Multicenter Study.
Basile Stamatopoulos, Thomas Smith, Emerence Crompot, Karlien Pieters, Ruth Clifford, Marek Mraz, Pauline Robbe, Adam Burns, Adele Timbs, David Bruce,[...]. Clin Cancer Res 2018
15
66

Clinicopathological features and outcomes of progression of CLL on the BCL2 inhibitor venetoclax.
Mary Ann Anderson, Constantine Tam, Thomas E Lew, Surender Juneja, Manu Juneja, David Westerman, Meaghan Wall, Stephen Lade, Alexandra Gorelik, David C S Huang,[...]. Blood 2017
94
66

Mutations in TLR/MYD88 pathway identify a subset of young chronic lymphocytic leukemia patients with favorable outcome.
Alejandra Martínez-Trillos, Magda Pinyol, Alba Navarro, Marta Aymerich, Pedro Jares, Manel Juan, María Rozman, Dolors Colomer, Julio Delgado, Eva Giné,[...]. Blood 2014
72
66

Final Results of a Randomized, Phase III Study of Rituximab With or Without Idelalisib Followed by Open-Label Idelalisib in Patients With Relapsed Chronic Lymphocytic Leukemia.
Jeff P Sharman, Steven E Coutre, Richard R Furman, Bruce D Cheson, John M Pagel, Peter Hillmen, Jacqueline C Barrientos, Andrew D Zelenetz, Thomas J Kipps, Ian W Flinn,[...]. J Clin Oncol 2019
85
66

Prognostic subgroups in B-cell chronic lymphocytic leukemia defined by specific chromosomal abnormalities.
G Juliusson, D G Oscier, M Fitchett, F M Ross, G Stockdill, M J Mackie, A C Parker, G L Castoldi, A Guneo, S Knuutila,[...]. N Engl J Med 1990
534
66


Acalabrutinib with or without obinutuzumab versus chlorambucil and obinutuzmab for treatment-naive chronic lymphocytic leukaemia (ELEVATE TN): a randomised, controlled, phase 3 trial.
Jeff P Sharman, Miklos Egyed, Wojciech Jurczak, Alan Skarbnik, John M Pagel, Ian W Flinn, Manali Kamdar, Talha Munir, Renata Walewska, Gillian Corbett,[...]. Lancet 2020
93
66

Genetic lesions associated with chronic lymphocytic leukemia transformation to Richter syndrome.
Giulia Fabbri, Hossein Khiabanian, Antony B Holmes, Jiguang Wang, Monica Messina, Charles G Mullighan, Laura Pasqualucci, Raul Rabadan, Riccardo Dalla-Favera. J Exp Med 2013
155
66

Venetoclax-Rituximab in Relapsed or Refractory Chronic Lymphocytic Leukemia.
John F Seymour, Thomas J Kipps, Barbara Eichhorst, Peter Hillmen, James D'Rozario, Sarit Assouline, Carolyn Owen, John Gerecitano, Tadeusz Robak, Javier De la Serna,[...]. N Engl J Med 2018
332
66

A new prognostic classification of chronic lymphocytic leukemia derived from a multivariate survival analysis.
J L Binet, A Auquier, G Dighiero, C Chastang, H Piguet, J Goasguen, G Vaugier, G Potron, P Colona, F Oberling,[...]. Cancer 1981
66

Lymphocyte doubling time in chronic lymphocytic leukaemia: analysis of its prognostic significance.
E Montserrat, J Sanchez-Bisono, N Viñolas, C Rozman. Br J Haematol 1986
267
66

Self-renewing hematopoietic stem cell is the primary target in pathogenesis of human chronic lymphocytic leukemia.
Yoshikane Kikushige, Fumihiko Ishikawa, Toshihiro Miyamoto, Takahiro Shima, Shingo Urata, Goichi Yoshimoto, Yasuo Mori, Tadafumi Iino, Takuji Yamauchi, Tetsuya Eto,[...]. Cancer Cell 2011
171
66

ERIC recommendations for TP53 mutation analysis in chronic lymphocytic leukemia-update on methodological approaches and results interpretation.
J Malcikova, E Tausch, D Rossi, L A Sutton, T Soussi, T Zenz, A P Kater, C U Niemann, D Gonzalez, F Davi,[...]. Leukemia 2018
67
66

Ibrutinib versus ofatumumab in previously treated chronic lymphoid leukemia.
John C Byrd, Jennifer R Brown, Susan O'Brien, Jacqueline C Barrientos, Neil E Kay, Nishitha M Reddy, Steven Coutre, Constantine S Tam, Stephen P Mulligan, Ulrich Jaeger,[...]. N Engl J Med 2014
982
66

Whole-genome sequencing identifies recurrent mutations in chronic lymphocytic leukaemia.
Xose S Puente, Magda Pinyol, Víctor Quesada, Laura Conde, Gonzalo R Ordóñez, Neus Villamor, Georgia Escaramis, Pedro Jares, Sílvia Beà, Marcos González-Díaz,[...]. Nature 2011
66

The reference epigenome and regulatory chromatin landscape of chronic lymphocytic leukemia.
Renée Beekman, Vicente Chapaprieta, Núria Russiñol, Roser Vilarrasa-Blasi, Núria Verdaguer-Dot, Joost H A Martens, Martí Duran-Ferrer, Marta Kulis, François Serra, Biola M Javierre,[...]. Nat Med 2018
69
66

Genomic characterization of high-count MBL cases indicates that early detection of driver mutations and subclonal expansion are predictors of adverse clinical outcome.
S Barrio, T D Shanafelt, J Ojha, K G Chaffee, C Secreto, K M Kortüm, S Pathangey, D L Van-Dyke, S L Slager, R Fonseca,[...]. Leukemia 2017
26
66

Near-tetraploidy is associated with Richter transformation in chronic lymphocytic leukemia patients receiving ibrutinib.
Cecelia R Miller, Amy S Ruppert, Nyla A Heerema, Kami J Maddocks, Jadwiga Labanowska, Heather Breidenbach, Gerard Lozanski, Weiqiang Zhao, Amber L Gordon, Jeffrey A Jones,[...]. Blood Adv 2017
20
66

B cell receptor signaling in chronic lymphocytic leukemia.
Jan A Burger, Nicholas Chiorazzi. Trends Immunol 2013
184
66


Co-cited is the co-citation frequency, indicating how many articles cite the article together with the query article. Similarity is the co-citation as percentage of the times cited of the query article or the article in the search results, whichever is the lowest. These numbers are calculated for the last 100 citations when articles are cited more than 100 times.